Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Synthon is an international, science-centered pharmaceutical company specializing in the development, manufacturing, and out-licensing of complex generic and hybrid medicines. Their mission is to make healthcare more affordable and accessible through scientific innovation, focusing on areas such as oncology, autoimmune diseases, and neurology. Synthon has a vertically integrated business model, from API (Active Pharmaceutical Ingredient) development and manufacturing to the finished dosage form product.
Global headquarters housing corporate functions, strategic leadership, research and development (R&D) laboratories, and pilot plant facilities for pharmaceutical development.
Modern facilities equipped with state-of-the-art R&D laboratories, designed to foster scientific collaboration and innovation. Located within Noviotech Campus, a hub for technology and life sciences.
A dynamic, international work environment driven by scientific excellence, collaboration, and a commitment to quality. Employees are typically focused on innovation and contributing to affordable healthcare solutions.
The central node for Synthon's global operations, R&D strategy, corporate governance, and international business development. Its location in a prominent European life sciences cluster enhances collaboration and talent acquisition.
Synthon maintains a significant global presence with functions spanning research and development (R&D), manufacturing of both APIs and finished dosage forms, quality assurance, regulatory affairs, and commercial operations. Key operational and R&D hubs are located in the Netherlands and the Czech Republic, with commercial offices and partners across Europe, Latin America, and Asia, enabling them to serve patients in over 100 countries worldwide.
Microweg 22
Nijmegen
Gelderland
Netherlands
Address: Synthon s.r.o., Brnenska 32/c.p. 597, 678 01 Blansko, Czech Republic
Serves as a central European hub for API production and advanced R&D, supplying Synthon's global needs and supporting the development of complex medicines.
Address: Synthon Argentina S.A., Av. Del Libertador 602, Piso 20, C1001ABT, Buenos Aires, Argentina
Manages and expands Synthon's commercial footprint and partnerships in the South American pharmaceutical market, tailoring strategies to local healthcare needs.
Address: Synthon Hispania S.L., Calle Orense, 16 – Planta 1, 28020 Madrid, Spain
Strengthens Synthon's API manufacturing capabilities within Europe and supports its commercial presence in Southern Europe.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Synthon' leadership includes:
Synthon has been backed by several prominent investors over the years, including:
Over the past year, Synthon experienced a notable change in its C-suite, particularly within its financial leadership. Mark Hersee was appointed as the new Chief Financial Officer, taking over from Jacques Lemmens.
Discover the tools Synthon uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Synthon primarily uses the [first].[last]@synthon.com email format for its employees. This is a common structure for professional communication within the company and with external partners. While other formats might exist in rare cases, this is the most prevalent.
[first].[last]@synthon.com
Format
jane.doe@synthon.com
Example
90%
Success rate
synthon.com • May 15, 2024
Synthon announced it will present updated clinical data for its anti-HER2 antibody-drug conjugate (ADC) trastuzumab duocarmazine (SYD985) at the European Society for Medical Oncology (ESMO) Breast Cancer 2024 congress, highlighting ongoing research in its oncology pipeline....more
synthon.com • February 20, 2024
Synthon's new state-of-the-art manufacturing facility for high-potent active pharmaceutical ingredients (HPAPIs) in Blansko, Czech Republic, successfully obtained Good Manufacturing Practice (GMP) certification, enhancing its in-house production capabilities....more
BC Partners News (via Synthon's reporting) • January 24, 2024
Synthon, a BC Partners portfolio company, announced the appointment of Mark Hersee as its new Chief Financial Officer, effective January 2024. He succeeds Jacques Lemmens, who stepped down in December 2023....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Synthon, are just a search away.